| Bioactivity | α-Glucosidase-IN-29 (compound 19) is a α-glucosidases inhibitor (IC50=1.21 μM, Ki=1.80 μM). α-Glucosidase-IN-29 ca be used for research of diabetes and related diseases[1]. |
| Target | IC50: 1.21 μM (α-Glucosidase);Ki: 1.80 μM (α-Glucosidase) |
| Name | α-Glucosidase-IN-29 |
| CAS | 2949513-11-3 |
| Formula | C33H30Br2O7 |
| Molar Mass | 698.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Phan TH, et al. Designing Potent 伪-Glucosidase Inhibitors: A Synthesis and QSAR Modeling Approach for Biscoumarin Derivatives. ACS Omega. 2023 Jul 11;8(29):26340-26350. |
α-Glucosidase-IN-29
CAS: 2949513-11-3 F: C33H30Br2O7 W: 698.40
α-Glucosidase-IN-29 (compound 19) is a α-glucosidases inhibitor (IC50=1.21 μM, Ki=1.80 μM). α-Glucosidase-IN-29 ca
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.